Convalescent Plasma: No Solid Evidence For or Against Its Use for COVID-19


NIH Not Recommending Convalescent Plasma

Health Editor’s Note: In what seemed likely to be a promising treatment for COVID-19 now, after reviewing all the available research, the opinion from the NIH is that there is no solid evidence for or against using convalescent plasma for treatment. 

Greater than 72,000 COVID-19 patients have been treated with convalescent plasma but now this treatment is not to be considered a ‘standard of care’ until more randomized, placebo-controlled clinical trials are completed.  

Some physicians will continue to use the treatment for the more critical cases since there is nothing else that is more effective.

VT was onboard with this treatment as it made total medical/scientific sense to place antibodies produced by those who have already contracted COVID-19 would cut the strength of COVID-19 infection since the body would be able to have some antibodies, although not those made by their own bodies, to fight the virus…..Carol 

Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy